Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medtronic reports second quarter fiscal 2023 financial results
November 22, 2022 6:45 AM ESTEarnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022.
Key Highlights
Revenue of $7.6 billion decreased 3% as reported and increased 2% organicGAAP diluted EPS of $0.32 decreased 67%; non-GAAP diluted EPS of $1.30 decreased 2%Company updates guidance; expects... More